Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool May 12, 2009 David Lee Smith	Dow Chemical Races Back Dow Chemical is wasting no time in shaping up after its Rohm and Haas purchase.
The Motley Fool July 31, 2009 David Lee Smith	Dow Chemical Calls U.S. Economy's Bottom With all sorts of buying and selling, Dow Chemical nevertheless smacks a solid quarter.
The Motley Fool February 4, 2011 David Lee Smith	Dow Chemical Is Packing a Punch Not far removed from acquisition difficulties, Dow Chemical posted one powerful quarter.
The Motley Fool April 29, 2010 David Lee Smith	Don't Tell Dow Chemical the Economy Is Soft Dow Chemical, a short time from its wild 2009, turns in one powerful quarter.
The Motley Fool March 13, 2009 David Lee Smith	Is Dow Chemical Ready for Another Deal? The Dow Chemical deal to buy Rohm & Haas lingered for eight months, but it's finally in the process of being put to bed. However, it appears that the last chapter of this saga may not yet have been written.
Chemistry World November 14, 2014 Katrina Kramer	Dow to sell nitroalkenes unit for $1.2bn Dow Chemical has agreed the sale of its subsidiary, nitroalkane specialist Angus Chemical, for $1.2 billion to investment company Golden Gate Capital.
The Motley Fool December 3, 2008 David Lee Smith	Dow Chemical's Nimble New Moves With its Kuwait venture saved and a solid acquisition, Dow Chemical is one to keep an eye on.
The Motley Fool January 12, 2010 David Lee Smith	Will 2010 Outclass 2009 for Dow Chemical? Despite a wild year in 2009, Dow Chemical is on fire.
The Motley Fool October 30, 2010 David Lee Smith	Dow Chemical Is Hitting on All Cylinders A little more than a year after a big acquisition, Dow Chemical is kicking bottom(s).
The Motley Fool May 4, 2009 David Lee Smith	Full Speed Ahead at Dow Chemical The company serves up an earnings surprise and a brightening outlook in its first quarter report..
The Motley Fool June 23, 2009 David Lee Smith	Valero Gets Cut Out of Dow Deal While Valero had announced an agreement to buy Dow's stake in Vlissingen, the U.S. refiner was ultimately squeezed by Total, which acquired and simultaneously sold Dow's portion of the unit to the Russian company.
The Motley Fool April 6, 2009 David Lee Smith	Debt-Laden Dow Chemical Buys and Sells The union of Dow Chemical and Rohm and Haas isn't all peaches and cream, with Dow facing an uphill struggle to pay off debt from the deal and stabilize its finances.
The Motley Fool December 14, 2010 David Lee Smith	Dow Chemical's A Worldwide Wonder Again Here's hoping you haven't missed Dow Chemical's growing global successes.
The Motley Fool August 5, 2010 David Lee Smith	Dow Chemical Appears to Be Cured With outages completed, and revenue climbing, Dow Chemical should be coming back.
The Motley Fool October 21, 2011 Neha Chamaria	1 Promising Stock You Shouldn't Miss Dow Chemical looks cheap on an absolute basis, and when compared to its peers on a trailing P/E basis.
The Motley Fool October 23, 2009 David Lee Smith	You Simply Can't Ignore Dow Chemical Throw in a major acquisition and balance sheet repairs and Dow still got it done.
The Motley Fool October 28, 2011 David Lee Smith	Dow Chemical Shows Shocking Strength Dow Chemical's share-price U-turn indicates a surprisingly strong quarter.
The Motley Fool January 28, 2005 Rich Smith	The Tao of Dow Overall, and despite a slew of one-time benefits and charges that skew the results somewhat, Dow Chemical managed to increase its profits by 57% in comparison to its 2003 results, earning its shareholders $2.93 per diluted share in 2004.
The Motley Fool October 29, 2007 David Lee Smith	Where Are You Going, Dow Chemical? While Dow Chemical reported a down quarter, the real question investors need to ask is its likely direction.
BusinessWeek July 26, 2004 David Henry	Rising Prices: Just The Catalyst Dow Needs The current wave of chemical price rises is going to last longer than anyone thought, delivering higher and higher profits to Dow well into 2006.
The Motley Fool January 31, 2008 Todd Wenning	Positive Adjectives Abound at Dow The chemical company is looking to grow all over the world.
The Motley Fool July 10, 2008 David Lee Smith	Buffett's Rohming, Too Dow's paying up for Rohm & Haas, but the deal looks good.
Chemistry World December 8, 2008 Matt Wilkinson	Dow wields the axe The company announced plans to 'eliminate' 5000 jobs, cast off several business units and idle around 30 per cent of its production plants.
The Motley Fool October 27, 2005 W.D. Crotty	One Word: Plastics Dow Chemical reports hearty sales growth for the third quarter. But there is a lot more for long-term investors to investigate.
The Motley Fool February 13, 2009 Alex Dumortier	More Crow, Mr. CEO? Dow Chemical CEO Andrew Liveris really should have known better than to make a promise about dividend cuts in this environment. After all, circumstances are apt to change rapidly and unexpectedly in the worst financial crisis since the Great Depression.
Chemistry World March 15, 2013 Andrew Turley	Dow makes $1.5bn divestiture plans US chemical giant Dow has announced plans to sell more parts of its 'non-core' business, adding that it will target an increased divestiture list of nearly $1.5 billion over the next 18 months.
The Motley Fool December 9, 2008 David Lee Smith	Dow's Cost-Cutting Chemistry Despite axing 5,000 workers, the chemical maker still merits attention.
The Motley Fool October 30, 2009 Brian Orelli	Pfizer Pfires Up Say on Pay It took six months from when shareholders asked for it, but Pfizer's board has finally given shareholders a voice on executive compensation.
The Motley Fool March 2, 2009 David Lee Smith	Is Help on the Way for Dow Chemical? Dow may have found new ways of funding its Rohm & Haas purchase.
Chemistry World May 7, 2015 Rebecca Trager	Dow to shed up to 1750 jobs by 2017 Dow Chemical will reduce its global workforce by roughly 3% as part of an effort to streamline the company and prepare for the spinoff of its chlorine business.
The Motley Fool December 29, 2008 David Lee Smith	Dow Chemical's Kuwait Deal Goes Kaboom Will Dow Chemical continue to chase Rohm & Haas now that its Kuwait deal has fizzled?
The Motley Fool April 25, 2008 David Lee Smith	Dow Almost Gets It Done Dow Chemical boosts across-the-board sales, but earnings falter.
The Motley Fool November 1, 2011 Neha Chamaria	Wow, Dow!! What a Performance! Why Dow Chemical is a superb chemical stock to have on your stock watchlist.
Chemistry World December 6, 2013 Emily James	Dow shakes out chlorine business Dow Chemical has unveiled plans to sell its chlorine business assets -- worth a total of $5 billion in annual revenue -- to make room for future spending.
The Motley Fool January 7, 2009 David Lee Smith	Dow Chemical Goes A-Courtin' Dow Chemical will travel the legal trail to salvage what it can from a cancelled joint venture with a state-owned Kuwaiti company.
BusinessWeek July 28, 2003 Gene G. Marcial	Why Dow Chemical Should Be a Buy Long-awaited relief may be around the corner for Dow Chemical. Although its stock has leaped from 25 in mid-March to 30 on July 16, the Street is far from convinced that the largest U.S. chemical company is out of the woods. But some pros think it's time to buy.
The Motley Fool November 1, 2004 Rich Smith	Buy the Dow The only discordant note in Dow Chemical's earnings report came from its cash-flow statement. The company's revenues for the quarter surpassed $10 billion, a 26% increase over Q3 2003.
The Motley Fool December 7, 2007 David Lee Smith	Dow Chemical's Not a Dazzler Yet Dow Chemical is planning a cost-reduction effort that will involve shutting down a number of plants and laying off about 1,000 employees, but the company's direction remains a mystery.
Chemistry World December 4, 2015 Rebecca Trager	Dow ditches older herbicides Dow will sell to Gowan its portfolio of dinitroaniline weedkillers, which came on the market in the 1960s.
The Motley Fool July 14, 2005 W.D. Crotty	Earnings Preview: Dow Chemical Dow expects strong second-quarter earnings. Long-term investors should consider that the industry's usual boom-bust cycle may be muted this time.
The Motley Fool March 26, 2009 David Lee Smith	Shifting Sands Favoring Dow Chemical Dow could benefit from big changes in Middle East refinery and petrochem projects.
The Motley Fool April 19, 2011 Jordan DiPietro	Should You Buy and Hold Dow Chemical? Dow has passed only one of our four tests for a good retirement stock, so it may not be the right choice for someone near or entering retirement.
The Motley Fool November 16, 2011 Dan Caplinger	Has Dow Chemical Become the Perfect Stock? Dow is clearly betting on renewed economic growth throughout the world. If it gets its wish, Dow could easily get even closer to perfection in the years ahead.
The Motley Fool December 31, 2008 David Lee Smith	Is Dow Chemical's Saudi Deal Going Sour? Uncertainty is building up around the company.
InternetNews June 29, 2005 Paul Shread	Technical Analysis: Stocks Stall At Resistance The Dow and Nasdaq paused at some key levels Wednesday.
The Motley Fool March 10, 2009 David Lee Smith	Dow's Headed Down the Aisle The purchase of Rohm and Haas by Dow Chemical, a saga that has seemingly lasted nigh onto forever, is over.
The Motley Fool October 3, 2005 W.D. Crotty	Good News: Dow's Down Dow Chemical's beat-up share price may be a boon to value investors.
Chemistry World October 29, 2008 James Mitchell Crow	Interview: Pierre Brondeau Pierre Brondeau, CEO-in-waiting of Philadelphia-based speciality chemicals company Rohm and Haas, is starting his new job on the day the company gets taken over by Dow Chemical.
The Motley Fool February 13, 2007 Selena Maranjian	Who's in "The Dow"? The Dow is an average based on the stock prices of 30 companies.
Chemistry World June 29, 2011 Rebecca Trager	Dow Boss to Lead $500M US Manufacturing Initiative President Obama has pledged over $500 million to jumpstart an initiative aimed at recovering US manufacturing leadership by investing in emerging technologies. But his appointment of the chief executive of chemical giant Dow, Andrew Liveris, to co-chair that effort has drawn criticism.